Wells Fargo & Company Issues Pessimistic Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target decreased by Wells Fargo & Company from $30.00 to $26.00 in a report published on Thursday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. APLS has been the topic of a number of other reports. Robert W. Baird […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target decreased by Wells Fargo & Company from $30.00 to $26.00 in a report published on Thursday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. APLS has been the topic of a number of other reports. Robert W. Baird […]
